EvaluatePharma Vision’s new enhancement, Product Specific PTRS, gives you a unique view of the likelihood of approval for any NME or NDA product across every stage of the development process.
Watch the video for a quick overview and fill in the form below to find out more.
In addition, other valuable new EvaluatePharma Vision enhancements include the ability to quickly identify products expected to be first to market; tailored views of the R&D pipeline through interactive visualizations; and the first comprehensive analysis of R&D trial costs based on real world data.
Don’t just know pharma, Evaluate it.
Thanks for your interest in Evaluate